MGC Pharmaceuticals Limited

MGC Pharmaceuticals Limitedverified

MGCLF

Price:

$0.2675

Market Cap:

$18.62M

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-02-22

Stock Exchange

PNK

Ticker

MGCLF

The PE Ratio as of November 2024 (TTM) for MGC Pharmaceuticals Limited (MGCLF) is -0.12

According to MGC Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.12. This represents a change of -92.02% compared to the average of -1.56 of the last 4 quarters.

MGC Pharmaceuticals Limited (MGCLF) Historical PE Ratio (quarterly & annually)

How has MGCLF PE Ratio performed in the past?

The mean historical PE Ratio of MGC Pharmaceuticals Limited over the last ten years is -5.97. The current -0.12 PE Ratio has changed 108.29% with respect to the historical average. Over the past ten years (40 quarters), MGCLF's PE Ratio was at its highest in in the June 2007 quarter at 0. The PE Ratio was at its lowest in in the September 2023 quarter at -3.80.

Quarterly (TTM)
Annual

Average

-5.97

Median

-4.48

Minimum

-24.05

Maximum

-0.85

MGC Pharmaceuticals Limited (MGCLF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of MGC Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 210.70%

Maximum Annual PE Ratio = -0.85

Minimum Annual Increase = -87.10%

Minimum Annual PE Ratio = -24.05

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.85-71.82%
2022-3.02-44.94%
2021-5.4876.54%
2020-3.10-87.10%
2019-24.05210.70%
2018-7.7451.76%
2017-5.10-3.17%
2016-5.2736.25%
2015-3.87204.49%
2014-1.27-65.30%

MGC Pharmaceuticals Limited (MGCLF) Average PE Ratio

How has MGCLF PE Ratio performed in the past?

The current PE Ratio of MGC Pharmaceuticals Limited (MGCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.11

5-year avg

-7.30

10-year avg

-5.97

MGC Pharmaceuticals Limited (MGCLF) PE Ratio vs. Peers

How is MGCLF’s PE Ratio compared to its peers?

MGC Pharmaceuticals Limited’s PE Ratio is greater than CBD Global Sciences Inc. (-0.28), greater than Target Group Inc. (-5.13), greater than Aequus Pharmaceuticals Inc. (-0.46), greater than Filament Health Corp. (-2.06), greater than Sky Century Investment, Inc. (-5.11), less than Levitee Labs Inc. (0), greater than Software Effective Solutions Corp. (-2.85), greater than The BC Bud Corporation (-2.50), less than Amexdrug Corporation (4.30), greater than Aion Therapeutic Inc. (-0.51), less than Aspen Pharmacare Holdings Limited (14.48), greater than Antisense Therapeutics Limited (-1.34),

Build a custom stock screener for MGC Pharmaceuticals Limited (MGCLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MGC Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MGC Pharmaceuticals Limited (MGCLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MGC Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is MGC Pharmaceuticals Limited's PE Ratio?

How is the PE Ratio calculated for MGC Pharmaceuticals Limited (MGCLF)?

What is the highest PE Ratio for MGC Pharmaceuticals Limited (MGCLF)?

What is the 3-year average PE Ratio for MGC Pharmaceuticals Limited (MGCLF)?

What is the 5-year average PE Ratio for MGC Pharmaceuticals Limited (MGCLF)?

How does the current PE Ratio for MGC Pharmaceuticals Limited (MGCLF) compare to its historical average?